Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 11Phase NA 5Phase 1/2 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 1

Status

Completed 12Unknown 8Terminated 6Recruiting 4Not yet recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Neoplasms 18Recurrence 17Pancreatic Neoplasms 17Multiple Myeloma 15Advanced Solid Tumors 13Prostatic Neoplasms 12Advanced Solid Tumor 12Stomach Neoplasms 10Ovarian Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Triple Negative Breast Neoplasms 8Neoplasm Metastasis 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Solid Tumor 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Endometrial Neoplasms 5

Interventions

toripalimab 1anlotinib 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Gemcitabine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Nasopharyngeal Carcinoma × Clear all
NCT07247201 2026-03-30

AlloNK1

Singapore General Hospital

Phase 1/2 Not yet recruiting
31 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm, Residual

NCT07320963 2026-03-20

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Sun Yat-sen University

Phase 1/2 Not yet recruiting
52 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05898256 2023-06-12

Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

Guangxi Medical University

Phase 1/2 Not yet recruiting
20 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡